Introduction
Problem
Solution
Success to Date
PhysiSens’s Rapid Success
- PhysiSens’s 2020 - 2021 Market Research Study & Validation Study validated the market need.
- To date, PhysiSens has raised $8,000 in non-equity funding. The Founder was one of the finalists in the Fairfield University StartUp Showcase, winning $3,000. Additionally, PhysiSens was awarded a research and development grant from the University of Bridgeport and CT Next for $5,000. They used the grant to research and develop and prove the viability and feasibility of their proof of concept.
- PhysiSens was one of 12 companies that was accepted into the Accelerator for Biosciences in Connecticut (ABCT) for the 2021 cohort. The company was recognized for leveraging, innovating, and pioneering multiple unique technologies to help solve the complex challenges of telerehabilitation.
- During their time at ABCT, PhysiSens made key connections with major hospitals and healthcare professionals to even further de-risk and validate the product.
- Proof of concept prototype created.
- Two Provisional Patents focusing on their innovative sensor systems and software technology using patent support from Wiggin and Dana LLP.
- PhysiSens is initiating an exceptionally strong, strategic patent portfolio, planning to file nine additional patent applications for their innovative technologies over the next few years.
Market
The Team:
Advisory Board
The Founder of PhysiSens has created a high caliber advisory board to help lead PhysiSens, including serial entrepreneurs, C-Suite executives, vetted technology professionals, and adept financial executives:
Business Model
Customer Acquisition, Pipeline, and Commercialization Partners:
PhysiSens has accumulated immense interest in their innovative technology from a plethora of large potential customers and potential commercialization partners, these companies include:
- Large digital health company
- Large, prestigious hospital
- Professional / Major League sports General Manager
- College sports team
- Medical divisions of the Department of Defense (DOD)
These potential future customers and commercialization partners plan on potentially licensing, testing, and/or partnering with PhysiSens in the future when the product becomes available.
The $500k raised from this round will allow PhysiSens to complete their technological research and development, produce market ready prototypes, and begin testing and licensing their innovative technology and software with their potential customers.
Use of Proceeds
If the offering's maximum amount of $500,000 is raised:
Use | Value | % of Proceeds |
---|---|---|
Compensation For Managers | $15,000 | 3.0% |
Employees / R&D | $420,000 | 84.0% |
Regulatory / FDA | $20,000 | 4.0% |
Intellectual Property | $20,500 | 4.1% |
Intermediary fees | $24,500 | 4.9% |
Terms
This number includes all funds raised by the Company in this round on Netcapital. This is an offering of Class A membership unit, under registration exemption 4(a)(6), in PhysiSens LLC. This offering must reach its target of at least $10,000 by its offering deadline of October 31, 2024 at 11:59pm ET. If this offering does not reach its target by the offering deadline, then your money will be refunded.
If the offering is successful at raising the maximum amount, then the company’s implied valuation after the offering (sometimes called its post-money valuation) will be:
Financials
These financial statements have been reviewed by an independent Certified Public Accountant.
SEC Filings
The Offering Statement is a formal description of the company and this transaction. It’s filed with the SEC to comply with the requirements of exemption 4(a)(6) of the Securities Act of 1933.
We’re also required to share links to each of the SEC filings related to this offering with investors.
Understand the Risks
Be sure to understand the risks of this type of investment. No regulatory body (not the SEC, not any state regulator) has passed upon the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials or information posted herein. That’s typical for Regulation CF offerings like this one.
Neither Netcapital nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.
The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
More Info
Updates
- Nov 1, 2024Primary offering finalized, sellingunits
- Apr 25, 2024Our Founder Winston DeMartini pitched to...
- Mar 25, 2024PhysiSens is very excited to announce that we...
- Mar 21, 2024PhysiSens conducted a research study;...
- Mar 17, 2024Customer Acquisition, Pipeline, and...
- Mar 16, 2024The delivery of remote therapy results in...
- Mar 9, 2024Did You Know That PhysiSens Has A Huge Market...
- Mar 6, 2024PhysiSens is very excited to announce that we...
Ask a Question
Proofread your comment before submitting: once it's posted, you can’t edit or delete it. Investors are advised to review our Discussion Board Policy before submitting a comment. For the fastest help with the web site, email help@netcapital.com instead of commenting.
Looking to raise capital?
We can help turn your friends, family and customers into investors.
Interested in more investment opportunities?
Browse all offerings currently available.